News

April 17, 2014 — Medtronic announced the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac resynchronization therapy-...

ICD, MADIT-CRT trial, long-term followup, ACC.14

Patients in mild heart failure who receive a cardiac resynchronization therapy defibrillator (CRT-D) device may live longer than those implanted with a traditional implantable...

Boston Scientific Ingevity Leads MRI Systems Pacemakers CRT EP Lab

Boston Scientific Corp. received CE marking and launched in Europe the Ingevity family of magnetic resonance imaging...

Boston scientific autogen x4 crt-d crt ICD heart failure cardiac

Boston Scientific Corp. has received CE mark approval of its X4 line of quadripolar ...

EP lab crt icd boston scientific europace

An independent study from the University of Pittsburgh Medical Center, published online this week in EP EuroPace, showed significant differences in battery longevity...

cardioverter defibrillator cardiac resynchronization therapy biotronik ilesto DX

The U.S. Food and Drug Administration (FDA) approved Biotronik’s Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices)....

Medtronic Inc. announced clinical trial results showing that heart failure patients treated with its AdaptivCRT feature experienced a nearly 50 percent reduction in atrial fibrillation (...

CardioMEMs

The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee will review two new technologies to help treat heart failure (HF) Oct. 8-9,...

Researchers announced this week that an attempt to expand cardiac resynchronization therapy (CRT) to include more patients with heart failure has failed and an international clinical trial ended...

Nanostim, leadless pacemaker

There have been several advances in electrophysiology (EP) technologies this past year, many of which were highlighted during the Heart Rhythm Society (HRS) 2013 scientific sessions earlier this...

July 25, 2013 — The 2013 ESC (European Society of Cardiology) Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy, developed in collaboration with the European Heart Rhythm...

June 28, 2013 — St. Jude Medical Inc. announced CE mark approval of its next-generation quadripolar device, the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D).

Medtronic Inc. announced new data demonstrating that simultaneously pacing the lower chambers of the heart, or biventricular (BiV) pacing with a cardiac resynchronization therapy (CRT) device,...

The American College of Cardiology and the American Heart Association released an expanded clinical practice guideline for the management of patients with heart failure, updating definitions and...

The incremental mortality in implantable pacemaker and defibrillator recipients who experience a device infection, compared to patients without device infection, is substantial and persists for at...

New data from 100,438 patients with Boston Scientific implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds...

St. Jude Medical Inc. has received CE Mark approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy...

Biotronik announced the U.S. Food and Drug Administration (FDA) granted approval for its Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D...

St. Jude Medical Inc., a global medical device company, has announced first enrollment of its MultiPoint Pacing clinical study to build upon its first- to-market Quadripolar Pacing System....

St. Jude Medical Inc. announced CE Mark approval and European launch of its Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P). This CRT-P system offers more pacing...

 Medtronic Inc. announced market release of the CardioGuide Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and defibrillators (CRT-P and...

Toshiba, activation imaging, ACC, 2013

This is a roundup of some of the DAIC editor's choice of the most innovative new technologies showcased at ACC 2013, including products in the areas of interventional cardiology, patient...

Biotronik Iforia ICD/CRT-D CE-Approval

Biotronik received CE mark for its most advanced ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device) series. Iforia is the world’s first DF4 ICD/CRT-D...

Cardiobridge, VAD, heart pump, hemodynamic support

The Heart Failure 2013 LA meeting will include a showcase of several startup companies offering innovative new approaches to address heart and cardiovascular disease.

ACC HRS Appropriate Use Criteria ICDs CRTs

The American College of Cardiology (ACC) and Heart Rhythm Society (HRS), along with key specialty societies, released appropriate use criteria for implantable cardioverter-defibrillators (ICDs)...

Medtronic Inc. announced it has received CE mark and will begin the European launch of the Attain Performa portfolio of quadripolar leads.

In response to the astounding percentage of inappropriate and non-compliant ICD, CRT-P and CRT-D device implantations each year, Think Tank Medical has developed and released its CMS ICD...

The U.S. Food and Drug Administration (FDA) has cleared St. Jude Medical’s new version of its Merlin.net Patient Care Network (PCN). The secure, Internet-based remote care system is for...

Evia HF-T  Biotronik Pacemaker Cardiac Resynchronization Therapy

Biotronik announced that high profile medical centers across the country are implanting the new Evia HF-T triple-chamber cardiac resynchronization therapy (CRT) pacemaker.

September 11, 2012 — St. Jude Medical Inc. announced the realignment of its product divisions into two new operating units: the Implantable Electronic Systems Division (IESD) and the...

August 30, 2012 — Implantable devices for treating cardiac arrhythmias, which include implantable cardioverter defibrillators (ICDs), are already underused in parts of Eastern and Central...

August 3, 2012 — In a bid to help control healthcare costs, on Oct 1, 2012, the Centers for Medicare and Medicaid Services (CMS) will stop paying hospitals for treating potentially avoidable...

ICD, CRT battery life

In the coming years, the continued growth and aging of our population will both increase the demand for treatment with implantable cardiac rhythm devices and stretch our ability to pay for care....

July 23, 2012 — Biotronik announced that the first CRT-D patient has been enrolled in the Biotronik EuroEco Trial — the European Health Economic Trial on Home Monitoring in...

The latest trends and newest cardiac rhythm management technology were highlighted during the biggest electrophysiology (EP) meeting in the world, Heart Rhythm Society (HRS) 2012 in May, held in...

May 14, 2012 ‑ Boston Scientific Corp. announced extended warranties of up to 10 years, depending on the model, for its Energen and Incepta ...

Sorin Group announced at the Heart Rhythm Society (HRS) annual scientific sessions, the publication of the CLEAR study results in Europace (May 1, 2012, doi:10.1093/europace/...

May 11, 2012 — The Sorin Group is launching new implantable devices with a proprietary algorithm system as well as three leads, and releasing data showing improved patient outcomes with a novel...

May 11, 2012 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of its Assura portfolio of...

May 9, 2012 — Boston Scientific Corp. announced U.S. Food and Drug Administration (FDA) approval and market launch of its Ingenio and Advantio pacemakers and Invive cardiac...

The U.S. Food and Drug Administration (FDA) approved an expanded indication for Medtronic’s cardiac resynchronization therapy with implantable cardioverter defibrillator (CRT-D) devices...

April 6, 2012 — St. Jude Medical announced it is proactively informing physicians about visual observations of externalized conductors on the silicone end of QuickSite and QuickFlex left...

St. Jude Medical has launched its Unify Quadra cardiac resynchronization therapy defibrillator (CRT-D) and Quartet left ventricular quadripolar pacing lead. It features four electrodes spaced over...

January 31, 2012 — Medtronic, Inc. announced U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a right ventricular lead and connector used with...

December 29, 2011 – Heart failure remains by far the single biggest reason for acute hospital admission but is stubbornly resistant to treatment. The prognosis for heart failure has been only...

November 18, 2011 – MedSolutions, a provider of medical cost management services, announced the launch of its implantable cardioverter defibrillator (ICD) surgery management program, which uses...

November 16, 2011 — MedSolutions announced the launch of its Implantable Cardioverter Defibrillator (ICD) Surgery Management Program. The system uses evidence-based guidelines to ensure the...

November 16, 2011 – Cambridge Consultants unveiled how it has collaborated with start-up company EBR Systems to develop the world’s first wireless pacing system.

October 18, 2011 — A U.S. Food and Drug Administration (FDA) committee will discuss and make recommendations to expand Medtronic’s indication for its cardiac resynchronization therapy...

August 29, 2011— The echocardiographic response (reduction of left ventricular end-systolic volume), evaluated at six months follow-up, proved a better predictor of long-term mortality than...

May 10, 2011 – The world's smallest and thinnest high-energy cardiac resynchronization therapy defibrillators (CRT-Ds) and implantable cardioverter defibrillators (ICDs) to treat heart failure and...
May 5, 2011 – A new warranty program is available in the United States that covers Boston Scientific’s cardiac resynchronization defibrillator (CRT-D) devices and leads in the event of chronic...

March 28, 2011 – The U.S. Food and Drug Administration (FDA) has approved two new cardiac resynchronization therapy-pacemaker (CRT-P) systems. The Consulta and Syncra CRT-P systems, from Medtronic...

March 1, 2011 – Medtronic, St. Jude Medical and Biotronik have emerged as leaders in the €2.8 billion European cardiac rhythm management (CRM) electrophysiology and ablation market, according to...

February 10, 2011 – Never before has a therapy proven more beneficial for women than men in preventing heart disease – until now.

January 24, 2011 – Boston Scientific has reached an agreement with Fukuda Denshi to market and sell its cardiac rhythm management (CRM) devices and accessories throughout Japan. Fukuda Denshi will...

December 29, 2010 – A new cardiac resynchronization therapy defibrillator (CRT-D) has been used in Canada for the first time. The Unify CRT-D, from St. Jude Medical, offers the smallest available...

December 3, 2010 – For the first time, data has shown that cardiac resynchronization therapy (CRT) is cost-effective in mildly symptomatic heart failure (HF) patients. Data from an economic sub-...

November 15, 2010 – Data from the RAFT clinical trial show that cardiac resynchronization therapy-defibrillators (CRT-Ds) significantly reduced mortality for mildly symptomatic heart failure...

October 29, 2010 – Site enrollment has been completed for the 50-site CITADEL and CENTURION clinical studies to evaluate the Tyrx AigisRx Antibacterial Envelope. The device is designed to help...

October 20, 2010 – New study results show that patients undergoing cardiac implantable electronic device (CIED) implantation had a 99.5 percent rate of successful implantation with an overall...

September 17, 2010 – The U.S. Food and Drug Administration (FDA) today expanded the indication for three cardiac resynchronization therapy defibrillators (CRT-D) to all classes of heart failure...

September 14, 2010 –To support proactive patient care for those at risk for worsening heart failure, Medtronic this week introduced the CareLink Network for Heart Failure. The remote monitoring...

September 8, 2010 – Total complications for new implantable cardioverter defibrillator (ICD) implants (including death in the laboratory) have decreased from 3.77 percent in 2006 to 2.87 percent...

July 27, 2010 – Results of the largest U.S. outpatient heart failure clinical study show that implementation of a process improvement program significantly improved adherence to evidence-based,...

July 8, 2010 – A new consensus statement released recently by the Heart Rhythm Society (HRS) offers guidance for managing cardiovascular implantable electronic devices (CIEDs) in patients nearing...

July 8, 2010 – Boston Scientific Corp. today announced enrollment of the first patient in its MultiSENSE clinical trial, which the company plans to use to develop a clinical alert identifying the...

June 21, 2010 – MADIT-CRT trial data shows women receive greater clinical benefit from cardiac resynchronization therapy defibrillators (CRT-Ds) than men, Boston Scientific Corp. announced last...

June 17, 2010 – The Protecta portfolio of defibrillators will soon be available in Europe. Medtronic Inc. today announced the European launch of the Protecta portfolio of implantable cardioverter-...

June 1, 2010 – A quadripolar pacing system was recently released in Europe and offers physicians the ability to more effectively manage the ever-changing pacing needs of patients with heart...

May 14, 2010 – New evidence demonstrates key shock-reduction programming strategies significantly reduced implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy...

May 13, 2010 – An integrated, break-away hemostasis valve is integrated into a new lead delivery system is designed to minimize blood loss and allow for easier implantation. The U.S.

May 11, 2010 – A cellular accessory has been added to an implantable cardiac device remote monitoring system to make it easier for patients to securely send information to their physicians. The...